Foster Dykema Cabot & Co »

Crispr Therapeutics shares owned by Foster Dykema Cabot & Co

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Foster Dykema Cabot & Co from 13F filings

Historical chart of Foster Dykema Cabot & Co investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Foster Dykema Cabot & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Foster Dykema Cabot & Co

Quarter filed Position value Share count Share price at filing
2023-09-30 $0 10 0.00
2023-06-30 $1.0k 10 100.00
2023-03-31 $0 10 0.00

More positions owned by Foster Dykema Cabot & Co

SPDR S&P 500 ETF Trust Etf (SPY)
JP Morgan USD UltraShort Income ETF Etf (JPST)
iShares Ultra Short-Term Bond ETF Etf (ICSH)
Amazon.com Common Stock (AMZN)
Microsoft Corporation Common Stock (MSFT)
Eli Lilly and Company Common Stock (LLY)
Costco Wholesale Corporation Common Stock (COST)
Amphenol Corporation Class A Common Stock (APH)
Quanta Services Common Stock (PWR)
Thermo Fisher Scientific Common Stock (TMO)
JPMorgan Chase & Co. Common Stock (JPM)
Berkshire Hathaway Inc. Class B Common Stock (BRK.B)
Vertex Pharmaceuticals Incorporated Common Stock (VRTX)
Industrial Select Sector SPDR Fund Etf (XLI)
Accenture Plc Class A Common Stock (ACN)

View all positions for Foster Dykema Cabot & Co

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
BlackRock
T. Rowe Price Investment Management
State Street Corporation
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics